Notice on Convening the 2nd Extraordinary General Meeting in 2025

About this update from Dashenlin Pharmaceutical Group Co., Ltd. Class A

Notice on Convening the 2nd Extraordinary General Meeting in 2025The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Dashenlin Pharmaceutical Group Co., Ltd. Class A